Form 4 for SNPS Synopsys
Accepted 2023-09-15 00:00:00 ET · period of report 2023-09-13 · accession 0001517737-23-000068 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-09-15 | 2023-09-13 | SNPS | RUNKEL JOHN F JR | GC, Corp. Sec | M - OptEx | $190.10 | +2,507 | 25.3K | +11% | +$476.6K |
| DM | 2023-09-15 | 2023-09-13 | SNPS | RUNKEL JOHN F JR | GC, Corp. Sec | S - Sale+OE | $455.00 | -2,507 | 24.7K | -9% | -$1.14M |
| DM | 2023-09-15 | 2023-09-13 | SNPS | RUNKEL JOHN F JR | GC, Corp. Sec | M - OptEx | $0.00 | -2,507 | 2,848 | -47% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-13 | M | A | 1,572 | $135.88 | 26,304 | D | — | — | |
| 2 | Common | Common Stock | 2023-09-13 | S | D | 1,572 | $455.00 | 24,732 | D | — | — | |
| 3 | Common | Common Stock | 2023-09-13 | M | A | 366 | $354.48 | 25,098 | D | — | — | |
| 4 | Common | Common Stock | 2023-09-13 | S | D | 569 | $455.00 | 24,732 | D | — | — | |
| 5 | Common | Common Stock | 2023-09-13 | S | D | 366 | $455.00 | 24,732 | D | — | — | |
| 6 | Common | Common Stock | 2023-09-13 | M | A | 569 | $234.17 | 25,301 | D | — | — | |
| 7 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-09-13 | M | D | 366 | $0.00 | 3,295 | D | $354.48 · 2022-12-09 to 2028-12-09 | 366 Common Stock | (F1) 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date. |
| 8 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-09-13 | M | D | 1,572 | $0.00 | 1,572 | D | $135.88 · 2020-12-12 to 2026-12-12 | 1,572 Common Stock | (F1) 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date. |
| 9 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-09-13 | M | D | 569 | $0.00 | 2,848 | D | $234.17 · 2021-12-10 to 2027-12-10 | 569 Common Stock | (F1) 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date. |